Month: November 2011

Stock Analysts

Medical Business Buoys Greatbatch (BSX) (GB) (JNJ) (MDT) (STJ)

November 1, 2011 0

Greatbatch ’s ( GB ) third-quarter fiscal 2011 adjusted (excluding one-time items) earnings per share of 41 cents outpaced both the Zacks Consensus Estimate and the year-ago adjusted earnings of 34 cents. Profit (as reported) soared 17% year over year to roughly $7 million (or 30 cents a share) owing to healthy sales from the New York-based company’s Orthopedic and Vascular businesses, supported by lower interest expense and tax. Revenues Revenues rose 3% year over year to $131.7 million, in line with the Zacks Consensus Estimate. […]

Stock Analysts

Mixed 3Q at Anadarko (APC) (BP) (COP)

November 1, 2011 0

Independent oil and gas producer Anadarko Petroleum Corporation 's ( APC ) third quarter 2011 operating earnings of 66 cents per share were in line with the Zacks Consensus Estimate. On a year-over-year basis, the company recorded significant growth from operating earnings of 25 cents per share in the third quarter 2010. […]

Mergers & Acquisitions

Direct Energy Closes Acquisition of First Choice Power

November 1, 2011 0

Direct Energy Closes Acquisition of First Choice Power Deal Strengthens Energy Company’s Texas business PR Newswire HOUSTON, Nov. 1, 2011 HOUSTON , Nov. 1, 2011 /PRNewswire/ — Direct Energy, one of North America ‘s largest competitive energy and energy-related services providers, has finalized its acquisition of residential and commercial energy retailer First Choice Power for $270 million in cash, plus additional working capital. […]

Stock Analysts

Allstate Profits Despite CAT Loss (ALL) (BRK.B) (TRV)

November 1, 2011 0

Allstate Corporation ’s ( ALL ) third quarter 2011 operating earnings of 16 cents per share came in a nickel higher than the Zacks Consensus Estimate of 11 cents but significantly lagged the year-ago quarter’s earnings of 83 cents per share. Results for the quarter reflected higher catastrophe (CAT) losses that also led to increased claims expenses coupled with lower average premiums and policies-in-force in Property-Liability insurance unit and lower investment income. However, prudent capital management and liquidity were quite impressive during the reported quarter […]

Stock Analysts

Pfizer Beats, Ups View (KKR) (PFE)

November 1, 2011 0

Pfizer Inc. ( PFE ) posted stronger-than-expected third quarter results. While third quarter earnings came in at 62 cents per share, well above the Zacks Consensus Estimate of 56 cents and 15% above the year-ago earnings, revenues increased 7% to $17.2 billion, beating the Zacks Consensus Estimate of $16.5 billion. […]

Stock Analysts

Haemonetics Disappoints in 2Q (HAE)

November 1, 2011 0

Haemonetics Corporation ( HAE ) reported an adjusted EPS of 72 cents in the second quarter of fiscal 2012, way below the Zacks Consensus Estimate of 77 cents and the year-ago quarter’s adjusted EPS of 80 cents. Headwinds that plagued the first quarter, such as the OrthoPAT devices recall and HS core bowl (to collect plasma for transfusion), continued to mar the current quarter performance. The company is working on remediation plans and expects to resolve the issues by the end of the current fiscal […]

Stock Analysts

S&P Ups Coca Cola Ratings Outlook (CCE) (KO) (PEP)

November 1, 2011 0

The rating agency, Standard & Poor's Ratings Services (“S&P”) has upgraded its ratings outlook on The Coca Cola Company ( KO ) on the back of the company’s strong operations and credit quality. Despite the prevailing market turmoil, S&P has revised Coca Cola’s outlook to “positive” from “stable” and reiterated "A+" long-term corporate credit and "A-1" short-term corporate credit and commercial paper ratings. The ratings agency continues to expect robust performance from Coca Cola even in the uncertain economic environment. […]